A 3 1/2-year clinical evaluation of resorbable hydroxylapatite OsteoGen (HA Resorb) used for sinus lift augmentations in conjunction with the insertion of endosseous implants.
A clinical study is presented of two cases in which resorbable hydroxylapatite [OsteoGen (HA Resorb), Stryker, Inc., Kalamazoo, MI] was used for sinus augmentation and sinus floor elevations. The insertion of endosseous titanium implants was done at the time of the sinus elevations.